Capital expenditure increased 33.2%
Capital expenditure changed +33.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +33.2% from the comparable as-filed period.
Cash & equivalents changed +31.1% from the comparable as-filed period.
Free-cash-flow proxy changed +543.7% from the comparable as-filed period.
Net income changed +28.6% from the comparable as-filed period.
Operating cash flow changed +184.0% from the comparable as-filed period.
Stock-based compensation changed +27.3% from the comparable as-filed period.
Inventory changed +7.7% from the comparable as-filed period.
Selling, general & administrative changed +9.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.